# Lilly Launches Single-Dose Vials of Zepbound for Weight Loss to Expand US Supply ## Key Points: – Eli Lilly and Company have introduced single-dose vials of Zepbound for weight loss to increase availability in the United States. – Zepbound is an FDA-approved medication designed to support weight management when used in combination with diet and exercise. – The new single-dose vials offer convenience and ease of use for individuals looking to incorporate Zepbound into their weight loss journey. – Lilly’s initiative aims to provide more options for healthcare providers and patients seeking effective solutions for managing weight and improving overall health. ### Eli Lilly and Company continues to innovate in the healthcare space by offering convenient solutions for weight management, like the new single-dose vials of Zepbound. This expansion of the US supply reflects Lilly’s commitment to supporting individuals on their path to better health through accessible and effective treatments. **Contact Mindful Evolution today to learn more about how Zepbound and other weight management solutions can support your journey towards a healthier lifestyle. Disclaimer: Individual results may vary. Mindful Evolution offers telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.**